Table 2. Differently expressed miRNAs in Barrett's metaplastic lesions.

miRNA	S/GM/IM sequence		S vs. GM			S vs. IM
	P	FDR-adjusted P	Fold change	P	FDR-adjusted P	Fold change	P	FDR-adjusted P
hsa-miR-18a*	<0.0001	<0.0001	0.00	<1e-07	<1e-07	0.01	1.0e-07	3.8e-05
hsa-miR-205	<0.0001	<0.0001	0.01	<1e-07	<1e-07	0.02	3.0e-07	5.6e-05
hsa-miR-203	<0.0001	0.0005	0.21	1.5e-05	0.001	0.21	1.2e-03	0.015
hsa-miR-20a	—	—	0.23	4.1e-03	0.017	0.26	6.3e-03	0.047
hsa-miR-106a	—	—	0.32	8.9e-03	0.031	0.27	8.6e-03	0.053
hsa-miR-20b	—	—	0.46	8.3e-05	0.004	—	—	—
hsa-miR-611	—	—	1.65	8.9e-03	0.031	—	—	—
hsa-miR-145	—	—	2.57	3.5e-05	0.002	—	—	—
hsa-miR-625*	—	—	2.58	3.4e-03	0.016	—	—	—
hsa-miR-192	<0.0001	0.0001	5.29	2.7e-05	0.002	—	—	—
hsa-miR-215	<0.0001	<0.0001	12.90	6.6e-06	0.001	16.81	2.4e-03	0.022
hsa-miR-194	<0.0001	0.0001	—	—	—	—	—	—

Abbreviations: FDR, false discovery rate; GM, gastric metaplasia; IM, intestinal metaplasia; miRNA, microRNA; S, squamous epithelium.